BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17578909)

  • 1. Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.
    Chang Y; Zuka M; Perez-Pinera P; Astudillo A; Mortimer J; Berenson JR; Deuel TF
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10888-93. PubMed ID: 17578909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.
    Perez-Pinera P; Chang Y; Deuel TF
    Cell Cycle; 2007 Dec; 6(23):2877-83. PubMed ID: 18156802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
    Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
    Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant.
    Zhang N; Zhong R; Wang ZY; Deuel TF
    J Biol Chem; 1997 Jul; 272(27):16733-6. PubMed ID: 9201975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.
    Perez-Pinera P; Chang Y; Astudillo A; Mortimer J; Deuel TF
    Biochem Biophys Res Commun; 2007 Jun; 358(2):399-403. PubMed ID: 17490616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer.
    Kumar S; Kishimoto H; Chua HL; Badve S; Miller KD; Bigsby RM; Nakshatri H
    Am J Pathol; 2003 Dec; 163(6):2531-41. PubMed ID: 14633625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.
    Chauhan AK; Li YS; Deuel TF
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):679-82. PubMed ID: 8421705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
    Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
    J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
    Maeda T; Desouky J; Friedl A
    Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
    Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H
    Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
    Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
    BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer.
    Perez-Pinera P; Garcia-Suarez O; Menendez-Rodriguez P; Mortimer J; Chang Y; Astudillo A; Deuel TF
    Biochem Biophys Res Commun; 2007 Oct; 362(1):5-10. PubMed ID: 17706593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotrophin stimulates tyrosine phosphorylation in NIH 3T3 and NB41A3 cells.
    Li YS; Deuel TF
    Biochem Biophys Res Commun; 1993 Sep; 195(2):1089-95. PubMed ID: 7690551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A pleiotrophin-specific siRNA and its effect on PTEN-/- MEF241 cells].
    Hu YC; Liu ML; Li G; Huo YY; Wu DC
    Ai Zheng; 2006 Oct; 25(10):1210-5. PubMed ID: 17059762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERp29, an endoplasmic reticulum secretion factor is involved in the growth of breast tumor xenografts.
    Mkrtchian S; Baryshev M; Sargsyan E; Chatzistamou I; Volakaki AA; Chaviaras N; Pafiti A; Triantafyllou A; Kiaris H
    Mol Carcinog; 2008 Nov; 47(11):886-92. PubMed ID: 18395818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis.
    Pufe T; Bartscher M; Petersen W; Tillmann B; Mentlein R
    Arthritis Rheum; 2003 Mar; 48(3):660-7. PubMed ID: 12632418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.
    Riegel AT; Wellstein A
    Breast Cancer Res Treat; 1994; 31(2-3):309-14. PubMed ID: 7533562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum stimulates Pleiotrophin gene expression in an AP-1-dependent manner in human endothelial and glioblastoma cells.
    Poimenidi E; Hatziapostolou M; Papadimitriou E
    Anticancer Res; 2009 Jan; 29(1):349-54. PubMed ID: 19331172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
    Grzelinski M; Bader N; Czubayko F; Aigner A
    Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.